Harmony Biosciences Holdings, Inc.

From Harmony Biosciences's results release of 4 noiembrie 2026; its quarterly report has since been filed.

• Revenue

  Actual

  268,9M USD

  +12 % y/y ↑
  +2,9 % q/q ↑

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  0,81 USD

  -6,9 % y/y ↓
  -37 % q/q ↓

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  54,2M USD

  -17 % y/y ↓
  -39 % q/q ↓

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.